Pleiotropic actions of suramin on the proliferation of human breast-cancer cellsin vitro

This publication has 17 references indexed in Scilit:

• Hydroxyapatite Assay to Measure Epidermal Growth Factor Receptor in Human Primary Breast Tumours
  Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1990
• Antiproliferative effects of suramin on androgen responsive tumour cells
  European Journal of Cancer and Clinical Oncology, 1990
• 4. The role of the epidermal growth factor receptor and the c-erbB-2 protein in breast cancer
  International Journal of Cancer, 1990
• Suramin, an anti‐cancer drug, inhibits protein kinase C and induces differentiation in neuroblastoma cell clone NB2A
  FEBS Letters, 1989
• Suramin inhibition of growth factor receptor binding and mitogenicity in AKR‐2B cells
  Journal of Cellular Physiology, 1987
• Blockade of autocrine stimulation in simian sarcoma virus-transformed cells reverses down-regulation of platelet-derived growth factor receptors.
  Proceedings of the National Academy of Sciences, 1984
• Coexpression of a PDGF-like growth factor and PDGF receptors in a human osteosarcoma cell line: Implications for autocrine receptor activation
  Cell, 1984
• Revision of the standards for the assessment of hormone receptors in human breast cancer; report of the second E.O.R.T.C. workshop, held on 16–17 March, 1979, in the Netherlands Cancer Institute
  Published by Elsevier ,1980
• Suramin: A potent inhibitor of the reverse transcriptase of RNA tumor viruses
  Cancer Letters, 1979
• Suramin: A potent ATPase inhibitor which acts on the inside surface of the sodium pump
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 1973